Human Tumour Type M2 Pyruvate Kinase,TU M2PK ELISA Kit

Contact us for 48 wells and bulk quote

Introducing the Human Tumour Type M2 Pyruvate Kinase, TU M2PK ELISA Kit, a cutting-edge solution designed to facilitate accurate and efficient detection of the M2 isoform of pyruvate kinase in human tumour samples. This advanced ELISA kit is meticulously crafted to cater to the needs of researchers and clinicians in the field of oncology, enabling them to gain valuable insights into tumour metabolism and aid in the diagnosis and monitoring of various malignancies.

The Human Tumour Type M2 Pyruvate Kinase, TU M2PK ELISA Kit boasts a comprehensive set of components, meticulously selected and rigorously tested to ensure optimal performance and reliability. The kit includes high-quality microtiter plates, pre-coated with specific antibodies targeting the M2 isoform of pyruvate kinase, guaranteeing exceptional sensitivity and specificity in detecting this critical biomarker.

With its user-friendly protocol, the TU M2PK ELISA Kit simplifies the experimental workflow, allowing for seamless integration into laboratory routines. The kit provides step-by-step instructions, enabling researchers to perform the assay with utmost precision and reproducibility. Moreover, the kit offers flexibility in sample types, accommodating a wide range of human tumour samples, thereby enhancing its versatility and applicability.

The Human Tumour Type M2 Pyruvate Kinase, TU M2PK ELISA Kit is renowned for its exceptional performance characteristics. It exhibits a wide dynamic range, enabling accurate quantification of M2 pyruvate kinase levels across a broad concentration spectrum. Additionally, the kit demonstrates remarkable sensitivity, detecting even low levels of the M2 isoform, thereby facilitating early detection and monitoring of tumour progression.

By utilizing the TU M2PK ELISA Kit, researchers and clinicians can unravel the intricate metabolic alterations associated with tumour development and progression. This invaluable tool empowers them to gain deeper insights into the underlying mechanisms driving malignancies, ultimately contributing to the advancement of personalized medicine and the development of novel therapeutic strategies.

In conclusion, the Human Tumour Type M2 Pyruvate Kinase, TU M2PK ELISA Kit stands as a pinnacle of innovation in the field of tumour biomarker detection. Its unrivaled performance, user-friendly design, and broad applicability make it an indispensable asset for researchers and clinicians alike, propelling the boundaries of oncological research and paving the way for improved patient care.